1. Home
  2. IMRX vs YSXT Comparison

IMRX vs YSXT Comparison

Compare IMRX & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • YSXT
  • Stock Information
  • Founded
  • IMRX 2008
  • YSXT 2011
  • Country
  • IMRX United States
  • YSXT China
  • Employees
  • IMRX N/A
  • YSXT N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • YSXT Automotive Aftermarket
  • Sector
  • IMRX Health Care
  • YSXT Consumer Discretionary
  • Exchange
  • IMRX Nasdaq
  • YSXT Nasdaq
  • Market Cap
  • IMRX 145.7M
  • YSXT 125.2M
  • IPO Year
  • IMRX 2021
  • YSXT 2024
  • Fundamental
  • Price
  • IMRX $3.52
  • YSXT $2.95
  • Analyst Decision
  • IMRX Strong Buy
  • YSXT
  • Analyst Count
  • IMRX 4
  • YSXT 0
  • Target Price
  • IMRX $13.25
  • YSXT N/A
  • AVG Volume (30 Days)
  • IMRX 486.1K
  • YSXT 205.1K
  • Earning Date
  • IMRX 08-19-2025
  • YSXT 08-15-2025
  • Dividend Yield
  • IMRX N/A
  • YSXT N/A
  • EPS Growth
  • IMRX N/A
  • YSXT N/A
  • EPS
  • IMRX N/A
  • YSXT 0.18
  • Revenue
  • IMRX N/A
  • YSXT $71,452,736.00
  • Revenue This Year
  • IMRX N/A
  • YSXT N/A
  • Revenue Next Year
  • IMRX N/A
  • YSXT N/A
  • P/E Ratio
  • IMRX N/A
  • YSXT $17.27
  • Revenue Growth
  • IMRX N/A
  • YSXT 22.04
  • 52 Week Low
  • IMRX $1.00
  • YSXT $2.06
  • 52 Week High
  • IMRX $4.69
  • YSXT $9.96
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 47.82
  • YSXT N/A
  • Support Level
  • IMRX $3.25
  • YSXT N/A
  • Resistance Level
  • IMRX $4.69
  • YSXT N/A
  • Average True Range (ATR)
  • IMRX 0.28
  • YSXT 0.00
  • MACD
  • IMRX -0.13
  • YSXT 0.00
  • Stochastic Oscillator
  • IMRX 18.76
  • YSXT 0.00

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares

YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.

Share on Social Networks: